Ventas has consistently been one of the top performing Healthcare REITs over the past five years. For the twelve month period ending March 31, 2008, it delivered a 11.8 percent annual total shareholder return. For the three year period ending March 31, 2008, the Company delivered a 27.4 percent annual total shareholder return and for the five year period Ventas delivered a 37.7 percent annual total shareholder return.

Ventas reported 2007 normalized Funds From Operations (FFO) of $2.69 per diluted share, a 10 percent increase over its 2006 normalized FFO per diluted share.  Ventas currently expects its 2008 normalized FFO to be between $2.75 to $2.82 per diluted common share.

The Company's 2008 indicated annual dividend is $2.05 per share, an eight percent increase over its 2007 dividend. Ventas offers a Distribution Reinvestment and Stock Purchase Plan (DRIP) that provides a convenient and economical means for Ventas shareholders and new investors to purchase common shares of the Company.

The Company's FFO and dividend estimates are based on a number of assumptions detailed in the Dividend and FFO Information section on this site. There can be no assurances regarding the Company's ability to pay future dividends or that the Company will achieve those results. The Company may from time-to-time update its publicly announced expectations regarding future FFO and dividends, but it is not obligated to do so.

Ventas's stock is traded on the New York Stock Exchange under the symbol VTR.